Chronic Myeloid Leukemia Philadelphia Chromosome-positive

• CLINICAL_TRIALS trial_result · 2019-12-10
  Clinical Trial Update: Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib [Phase 3]

  A Phase 3 trial evaluating switching from imatinib to nilotinib to improve chronic low-grade adverse events in patients with Philadelphia-po…